✦ LIBER ✦

Switching to long-acting injectable risperidone: Beneficial with regard to clinical outcomes, regardless of previous conventional medication in patients with schizophrenia

✍ Scribed by M.A. Latif; P. Saleem; P. Glue; W.J. Arnoldussen; R. Teijeiro; A. Lex; T. De Marinis

Book ID: 118438319
Publisher: Elsevier Science
Year: 2007
Tongue: French
Weight: 46 KB
Volume: 22
Category: Article
ISSN: 0924-9338
DOI: 10.1016/j.eurpsy.2007.01.516

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of switching to long-acting inje

Effects of switching to long-acting injectable risperidone from oral atypical antipsychotics on cognitive function in patients with schizophrenia

✍ Sung-Wan Kim; Il-Seon Shin; Jae-Min Kim; Seung-Hyun Lee; Yo-Han Lee; Su-Jin Yang 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 2 views

## Abstract ## Objective To investigate changes in cognitive function and clinical features following a switch from oral atypical antipsychotics (AAPs) to long‐acting injectable risperidone (LAIR) in patients with schizophrenia. ## Methods Thirty‐six patients with schizophrenia treated with oral

P.3.011 Patients treated with different

P.3.011 Patients treated with different conventional depot medications improve similarly after switch to risperidone long-acting injectable

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 226 KB

AD2 Cost-Consequence Analysis of Switchi

AD2 Cost-Consequence Analysis of Switching From An Oral Antipsychotic To Long Acting Injectable Risperidone Among Patients With Schizophrenia

✍ L. Degli Esposti; D. Sangiorgi; S. Buda 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB

Switching stable patients with schizophr

Switching stable patients with schizophrenia from depot and oral antipsychotics to long-acting injectable risperidone: efficacy, quality of life and functional outcome

✍ Keith Lloyd; Muhammud A. Latif; Steve Simpson; Keshar L. Shrestha 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB 👁 2 views

## Abstract ## Objective This international, non‐randomised study evaluated maintained efficacy and safety of Risperidone Long‐Acting Injectable (RLAI) compared to previous medications. To investigate the possible effect of differences in national health care systems across Europe, the UK subset e

Pharmacokinetics and efficacy of a direc

Pharmacokinetics and efficacy of a direct switch from conventional depot to risperidone long-acting injection in Chinese patients with schizophrenic and schizoaffective disorders

✍ Ying-Ching Lai; Ming-Chyi Huang; Chun-Hsin Chen; Chang-Jer Tsai; Chun-Hung Pan; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

A 6-month randomized open-label comparis

A 6-month randomized open-label comparison of continuation of oral atypical antipsychotic therapy or switch to long acting injectable risperidone in patients with bipolar disorder

✍ L. N. Yatham; A. Fallu; C. E. Binder 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB